Clinical Trial Update: Seasonal Malaria Chemoprevention With or Without Lipid-based Nutrient Supplement in Children Aged 6-59 Months in Mali [NA]

View source ↗

Summary

A completed clinical trial in Mali evaluated seasonal malaria chemoprevention with or without a lipid-based nutrient supplement in children aged 6-59 months.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• Sulfadoxine-pyrimethamine plus amodiaquine (sulfadoxine-pyrimethamine and amodiaquine)
• lipid-based nutrient supplement (lipid-based nutrient supplement)

Snippet

Sponsor: Alliance for International Medical Action | Conditions: Malaria | NA | Status: COMPLETED